Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)
Ontology highlight
ABSTRACT: This randomized comparative study aims to evaluate the satisfaction and quality of life of patients using Cicaplast balm B5, versus Dexeryl, for the management of cutaneous toxicities of iEGFR in squamous cell carcinoma of the head and neck, cancers colorectal or pulmonary
DISEASE(S): Squamous Cell Carcinoma Of Head And Neck,Carcinoma,Epidermal Growth Factor Receptor Inhibitor,Colorectal Cancer,Colorectal Neoplasms,Non Small Cell Lung Cancer,Head And Neck Squamous Cell Carcinoma,Lung Neoplasms
PROVIDER: 2265007 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA